Breaking News

A Baldness Breakthrough?

May 2, 2013

DS Healthcare launches Spectral.DNC-N.

DS Healthcare Group Inc. has launched Spectral.DNC-N, which it calls the first product to incorporate the proprietary Nanoxidil compound, a powerful, gentle, nondrug alternative to minoxidil. The new product is formulated to help stimulate hair across the entire scalp. It employs the Nanosome-encapsulation system -- proprietary to the company's DS Laboratories brand -- to transport ingredients deeper into follicles for more effective results.

Spectral.DNC-N is the latest addition to the Spectral line, the first topical treatment series to address more than 20 potential causes of hair thinning and loss. Spectral products target these challenges with multiple bioactive ingredients to promote follicle rejuvenation throughout the entire scalp, as minoxidil does at the vertex.

The new formula was created to surpass the results obtained from older products. The nondrug biotechnology is lightweight, easy to use, and does not leave a heavy, greasy, or unsightly residue, which is common with mass-market hair-growth products.

In the hair follicle, Spectral.DNC-N generates adenosine triphosphate, the universal currency of bioenergy, and deposits a multitude of key compounds via sophisticated delivery systems. The formula is anti-inflammatory and antihormonal and delivers hydration, nutrition, stimulation, and rejuvenation.

New Nanoxidil 5%, a key compound in the product, has a lower molecular weight and does not require the chemical solvents that often irritate scalp. It works well for women with noticeable thinning and for men in the early or moderate stages of thinning. It benefits users with receding hairlines or patchy eyebrows and serves as an overall preventative therapy.

Uniquely lightweight and comfortable to use, Spectral.DNC-N contains procyanidin B-2 (apple polyphenol) to encourage hairline as well as vertex growth, retinol for better absorption, adenosine for cellular repair, patented Aminexil to counter perifollicular fibrosis, copper peptides to fight scalp inflammation, and herbal extracts to support a healthy and comfortable overall condition.

DS Healthcare Group Inc. leads in the development of biotechnology for topical, and nutritional therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its brands include DS Laboratories (www.DSLaboratories.com), Sigma Skin (www.SigmaSkin.com), Polaris Research Laboratories (www.PolarisReserachLabs.com) and The Pure Guild (www.ThePureGuild.com).

blog comments powered by Disqus
  • Patent Update

    Patent Update

    June 30, 2016
    J&J's anti-aging patent, LVMH and cannabis essential oil, transdermal botulinum toxins and more in recent patent news.

  • Start Stuffing The Ballot Box (Again)!

    Start Stuffing The Ballot Box (Again)!

    June 28, 2016
    Vote on the finalists in Happi's reader's choice Anti-Aging Product of the Year contest!

  • What

    What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 27, 2016
    Euromonitor weighs in on how Brexit could impact consumer product companies.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.